Oncology & Cancer

New system finds and targets vulnerabilities in lung cancer cells

Genetic changes that help lung cancer thrive also make it vulnerable to a promising experimental drug, according to a study led by researchers from Perlmutter Cancer at NYU Langone Health, and published online October 2 in ...

Diseases, Conditions, Syndromes

Interstitial lung abnormalities linked to increased mortality

(HealthDay)—Interstitial lung abnormalities correlate with increased risk of all-cause mortality, according to research published in the Feb. 16 issue of the Journal of the American Medical Association.

Oncology & Cancer

Targeted therapy boosts lung cancer outcomes

–Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber ...

page 1 from 3